Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans

[1]  L. Zagato,et al.  Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. , 2006, Journal of the American College of Cardiology.

[2]  M. Entman,et al.  Regulatable atrial natriuretic peptide gene therapy for hypertension. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Gigante,et al.  Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in Humans , 2004, Stroke.

[4]  F. Cappuccio,et al.  Genetic Variation in the ReninAngiotensin System and Abdominal Adiposity in Men: The Olivetti Prospective Heart Study , 2003, Annals of Internal Medicine.

[5]  Ali G. Gharavi,et al.  Molecular Mechanisms of Human Hypertension , 2001, Cell.

[6]  Y. Yazaki,et al.  Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. , 2000, Clinical science.

[7]  H. S. Kim,et al.  Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Kreutz,et al.  HpaII-polymorphism of the atrial-natriuretic-peptide gene and essential hypertension in whites. , 1997, American journal of hypertension.

[9]  O. Smithies,et al.  Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension , 1995, Science.

[10]  L. Field,et al.  Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. , 1990, Hypertension.

[11]  D. Gardner,et al.  N ATRIURETIC P EPTIDES , 1998 .

[12]  R. Ward.  Familial aggregation and genetic epidemiology of blood pressure , 1990 .